A. DOYON Et Al. , "Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study," The 16th Congress of IPNA , vol.28, Shangai, China, pp.1325-1346, 2013
DOYON, A. Et Al. 2013. Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study. The 16th Congress of IPNA , (Shangai, China), 1325-1346.
DOYON, A., FISCHER, D., BAYAZIT, A. K., CANPOLAT, N., SOZERI, B., BACCHETTA, J., ... GONDAN, M.(2013). Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study . The 16th Congress of IPNA (pp.1325-1346). Shangai, China
DOYON, ANKE Et Al. "Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study," The 16th Congress of IPNA, Shangai, China, 2013
DOYON, ANKE Et Al. "Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study." The 16th Congress of IPNA , Shangai, China, pp.1325-1346, 2013
DOYON, A. Et Al. (2013) . "Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study." The 16th Congress of IPNA , Shangai, China, pp.1325-1346.
@conferencepaper{conferencepaper, author={ANKE DOYON Et Al. }, title={Impact Of Recombinant Growth Hormone Therapy On Bone Metabolism In Children With Chronic Kidney Disease (CKD): Findings From The 4C Study}, congress name={The 16th Congress of IPNA}, city={Shangai}, country={China}, year={2013}, pages={1325-1346} }